CAS 339086-80-5

Tadocizumab

CAS: 339086-80-5

Tadocizumab (C4G1) is a humanized monoclonal antibody targeting integrin αIIbβ3 with antiplatelet and antithrombotic effects.

Reinheit: 97.1% (SDS-PAGE); 97.2% (SEC-HPLC) - 97.1% (SDS-PAGE); 97.2% (SEC-HPLC)

Farbe und Form: Transparent Liquid

Molekulargewicht: 47.59 kDa (Predicted)

Ref: TM-T76979

Tadocizumab

CAS: 339086-80-5

Reinheit: 95%

Molekulargewicht: G/Mol

Ref: IN-DA02EOBJ